about
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differ...
Read More
92.68
6.68
(7.77%)
1.3M
XNAS Volume
XNAS 14 Nov, 2025 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Bullish
Celcuity Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..